Michael Theisen

Michael Theisen

Professor

Member of:

  • GLURP team

ORCID: 0000-0003-4412-1392

Publication year:
All
91 - 100 out of 110Page size: 10
Sort by: 1st author
  1. Published

    Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine

    Singh, S. K., Plieskatt, J., Chourasia, B. K., Singh, V., Bengtsson, K. L., Reimer, J. M., van Daalen, R. C., Teelen, K., van de Vegte-Bolmer, M., van Gemert, G., Jore, M. M. & Theisen, Michael, 2021, In: npj Vaccines. 6, 11 p., 120.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies

    Singh, S. K., Roeffen, W., Andersen, G., Bousema, T., Christiansen, M., Sauerwein, R. & Theisen, Michael, 15 Apr 2015, In: Vaccine. 33, 16, p. 1981-6 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Pfs230 and Pfs48/45 fusion proteins elicit strong transmission-blocking antibody responses against Plasmodium falciparum

    Singh, S. K., Thrane, Susan, Chourasia, B. K., Teelen, K., Graumans, W., Stoter, R., van Gemert, G., van de Vegte-Bolmer, M. G., Nielsen, Morten Agertoug, Salanti, Ali, Sander, Adam F. , Sauerwein, R. W., Jore, M. M. & Theisen, Michael, 2019, In: Frontiers in Immunology. 10, 1256.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Lactococcus lactis provides an efficient platform for production of disulfide-rich recombinant proteins from Plasmodium falciparum

    Singh, S. K., Tiendrebeogo, R. W., Chourasia, B. K., Kana, Ikhlaq Hussain, Singh, S. & Theisen, Michael, 2018, In: Microbial Cell Factories. 17, 13 p., 55.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine

    Singh, S. K., Roeffen, W., Mistarz, U. H., Chourasia, B. K., Yang, F., Rand, Kasper Dyrberg, Sauerwein, R. W. & Theisen, Michael, 2017, In: Microbial Cell Factories. 16, 1, 11 p., 97.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Cloning and recombinant protein expression in Lactococcus lactis

    Singh, S. K., Naghizadeh, Mohammad, Plieskatt, J., Singh, S. & Theisen, Michael, 2023, Advanced Methods in Structural Biology. Sousa, Â. & Passarinha, L. (eds.). Humana Press, p. 3-20 18 p. (Methods in Molecular Biology, Vol. 2652).

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

  7. Published

    A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children

    Sirima, S. B., Mordmüller, B., Milligan, P., Ngoa, U. A., Kironde, F., Atuguba, F., Tiono, A. B., Issifou, S., Kaddumukasa, M., Bangre, O., Flach, C., Christiansen, M., Bang, P., Chilengi, R., Jepsen, S., Kremsner, P. G. & Theisen, Michael, Aug 2016, In: Vaccine. 34, 38, p. 4536-4542 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    The candidate blood-stage malaria vaccine P27A induces a robust humoral response in a fast track to the field Phase 1 trial in exposed and nonexposed volunteers

    Steiner-Monard, V., Kamaka, K., Karoui, O., Roethlisberger, S., Audran, R., Daubenberger, C., Fayet-Mello, A., Erdmann-Voisin, A., Felger, I., Geiger, K., Govender, L., Houard, S., Huber, E., Mayor, C., Mkindi, C., Portevin, D., Rusch, S., Schmidlin, S., Tiendrebeogo, R. W., Theisen, M. & 9 others, Thierry, A., Vallotton, L., Corradin, G., Leroy, O., Abdulla, S., Shekalaghe, S., Genton, B., Spertini, F. & Jongo, S. A., 2019, In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 68, 3, p. 466-474 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity

    Stone, W. J. R., Campo, J. J., Ouédraogo, A. L., Meerstein-Kessel, L., Morlais, I., Da, D., Cohuet, A., Nsango, S., Sutherland, C. J., van de Vegte-Bolmer, M., Siebelink-Stoter, R., van Gemert, G-J., Graumans, W., Lanke, K., Shandling, A. D., Pablo, J. V., Teng, A. A., Jones, S., de Jong, R. M., Fabra-García, A. & 14 others, Bradley, J., Roeffen, W., Lasonder, E., Gremo, G., Schwarzer, E., Janse, C. J., Singh, S. K., Theisen, Michael, Felgner, P., Marti, M., Drakeley, C., Sauerwein, R., Bousema, T. & Jore, M. M., 8 Feb 2018, In: Nature Communications. 9, 1, 14 p., 558.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations

    Tamborrini, M., Stoffel, S. A., Westerfeld, N., Amacker, M., Theisen, Michael, Zurbriggen, R. & Pluschke, G., 2011, In: Malaria Journal. 10, p. 359

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...6 7 8 9 10 11 Next

ID: 10528769